By Ian Walker AstraZeneca shares are up and leading the FTSE 100 index risers after the company said that its lung-cancer treatment Tagrisso, together with.
By Elena Vardon AstraZeneca sees its revenue and core earnings per share growing by double-digit percentages in 2024, the pharmaceuticals major said as it.
The drugmaker AstraZeneca reported underwhelming earnings for its fourth quarter, as sales of a handful of its cancer medicines came in below investor.
By Elena Vardon AstraZeneca sees its revenue and core earnings per share growing by double-digit percentages in 2024, the pharmaceuticals major said as it.
By Elena Vardon AstraZeneca is scheduled to report results for its fourth quarter on Thursday. Here is what you need to know: REVENUE: The Anglo-Swedish.